UF Startup and Sid Martin graduate company Morphogenesis, says it is getting closer to a shot that would treat some skin cancers.
UF Health is now the first site in the southeastern United States to house a groundbreaking device that will provide personalized cancer treatment by combining extremely detailed magnetic resonance imaging, or MRI, with precision radiotherapy.
A group of scientists in Tampa is working to make treating cancer as easy as getting a shot. While most of today's cancer treatments tend to be toxic and expensive, UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a clinical-stage biotechnology company, is working to develop immunotherapies that are safe and affordable.
DiaCarta is initiating a large-scale clinical development program, which will monitor cfDNA levels to determine early treatment outcomes of systemic therapy in all types of stage IV cancer.
Many drug research efforts occurring at UF are focused on marine and natural products that will lead to advancements in medications and treatments for cancers. Dr. Hendrik Luesch was involved in a recent discovery of a marine compound off the east coast of Florida named gatorbulin-1 that could potentially be used in the fight against cancer; this discovery highlights the importance of searching the ocean’s biodiversity.
UF startup Dialectic Therapeutics, Inc., a Texas-based biotechnology company focused on creating innovative new technologies to treat cancer, announced that the U.S. Food and Drug Administration (FDA) has concluded that Dialectic may proceed with its clinical investigation for its lead product candidate, DT2216, a unique compound built using its proprietary and novel Antiapoptotic Protein Targeted Degradation (APTaD) technology.